Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
For full access to this article login to GEN Select now.
$1,000 Genome Remains the Holiest
Innovations and Advances Move Sequencing Forward, But the Ultimate Goal Will Continue to Be Elusive
- With the advent and development of high-throughput technologies, DNA sequencing takes center stage as a powerful tool in decoding genetic information. However, the goal of sequencing many genomes in parallel can only be made by considerable reduction in sequencing costs. A price tag of $1,000 per three gigabases—the size ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.